Saturday, September 03, 2016 8:01:59 AM
Advent of Nanomaterials is Expected to Revolutionize Biomaterials Market: TMR Published on 2016-09-02. Author : SpecialChem
The global biomaterials market for implantable devices is currently exhibiting a highly fragmented vendor landscape. The presence of a large number of companies has triggered intense rivalry among the existing players. As an inevitable response to the prevailing competition, these companies have been engaged in extensive research and development activities. Enterprises such as AdvanSource Biomaterials Corp., Celanese Corp., Evonik Industries AG, DuPont, and others have been investing in technological developments to rake in higher revenues
http://omnexus.specialchem.com/news/industry-news/nanomaterials-revolutionize-biomaterials-market-000183552
Recent NORD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2024 07:02:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/15/2023 05:15:19 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/06/2023 08:46:07 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/27/2023 10:16:50 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM